bonyf NV (Ticker: MLBON), a leading name in dental consumer products, characterizes the strategic shift being undertaken by the Group as the “Renaissance of bonyf”.
PerioCream constitutes a key element of this revitalized approach. The initial European launches commence in September, and a steadily expanding array of international prospects lies ahead.”— Jean Pierre Bogaert, Chairman CEO of bonyf NVKNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, September 12, 2026 /EINPresswire.com/ — bonyf NV (Ticker: MLBON), a frontrunner in dental consumer goods, professional dental consumables and dermatological solutions, defines the restructuring being executed by the Group as the “Renaissance of bonyf”: a return to the entrepreneurial, brand‑centric model that powered the Company’s most successful period from 1980 to 2000.
That era, considered the peak years of bonyf AG, saw the Company focus chiefly on creating, producing and marketing its own products. Contract manufacturing for third parties made up only a small share of its operations.
Over time, a mix of market dynamics and strategic choices led bonyf to redirect a large portion of its commercial energy away from owned brands toward private‑label production and product creation for outside partners. While this opened up fresh avenues, it also introduced a more intricate business framework and diminished the priority given to international expansion of bonyf’s proprietary labels.
As previously disclosed in earlier press releases, bonyf has started a deliberate return to its origins. The Group is steadily concentrating its efforts on the marketing and global distribution of its own products, aiming to build a more streamlined, identifiable and value‑oriented product lineup.
PerioCream at the centre of the international strategy
Alongside the renewed growth of its existing brands, bonyf is investing heavily in building worldwide distribution of PerioCream, its premium, high‑end product for professional periodontal care.
The initial commercial roll‑outs of PerioCream are scheduled for September 2026 in Italy, Poland, Spain, Croatia and Slovenia. Talks with prospective distributors in numerous other countries are advancing, resulting in a growing global pipeline.
The United States stands out as one of the most significant future markets for PerioCream. Subject to securing the necessary approval from the U.S. Food and Drug Administration (FDA), bonyf intends to begin its entry into the American market, potentially before the close of 2026. The timing of any U.S. launch will continue to depend on the progress and outcome of the relevant regulatory process.
Jean-Pierre Bogaert, CEO of bonyf, remarked:
“We are returning to the fundamentals that made bonyf successful during its golden years: innovation, strong proprietary products and direct investment in the development of our own brands. PerioCream constitutes a key element of this revitalized approach. With the initial European launches commencing in September and a steadily expanding array of international prospects lies ahead, I am very confident that we can realize a true Renaissance of bonyf in the coming years.”
Through this strategic overhaul, bonyf aims to simplify its commercial model, boost the visibility of its own brands and establish a more solid basis for sustainable global growth.
Jean-Pierre Bogaert
bonyf AG
+41 79 412 42 79
email us here
Visit us on social media:
LinkedIn
About bonyf
